Jeffrey Friedman
Director/Board Member at DTx Pharma, Inc.
Profile
Jeffrey S.
Friedman is currently the Director at DTx Pharma, Inc. since 2018.
He previously worked as the Director at Celsense, Inc.
Jeffrey Friedman active positions
| Companies | Position | Start |
|---|---|---|
DTx Pharma, Inc.
 DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Director/Board Member | 31/03/2018 |
Former positions of Jeffrey Friedman
| Companies | Position | End |
|---|---|---|
Celsense, Inc.
 Celsense, Inc. Medical DistributorsDistribution Services Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Celsense, Inc.
Celsense, Inc. Medical DistributorsDistribution Services Celsense, Inc. operates as a biotechnology company. It offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The firm’s products include Cell Sense and V-Sense. Its products are used in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. The company was founded by Eric T. Ahrens on July 12, 2005 and is headquartered in Pittsburgh, PA. | Distribution Services |
DTx Pharma, Inc.
DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Friedman